The new drugs, with Ozempic at the forefront, will not be enough to combat it. We must attack the root of the problem: poverty and social inequality.
According to the WHO, 16% of adults in the world suffer from this disease. It also affects 160 million children and adolescents and carries social and, sometimes, medical stigma. After decades of failed fight against the disease, health professionals are seeing how this drug not only reduces weight without having to mistakenly appeal to patients' willpower.